Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06752603

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

Conditions: Hunner Type Interstitial Cystitis

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 57
Sponsor: Ono Pharmaceutical Co., Ltd.

Location: Nagoya University Hospital Nagoya Aichi-ken

Summary

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Hunner Type Interstitial Cystitis

Eligibility Criteria

Inclusion Criteria: * Japanese (both sexes) * Age (at the time of informed consent): 18 years and older * Outpatient * Patients who are considered capable of understanding the study procedures and completing the pain diary, bladder diary, and questionnaires appropriately by the investigator (sub-investigator) * Patients given a diagnosis of HIC by cystoscopy * Patients with chronic pelvic pain involving the bladder and lower urinary tract symptoms such as increased micturition and pollakiuria Exclusion Criteria: * Patients with a history and presence of chemical cystitis * Patients with a history of bladder augmentation or radical cystectomy * Patients with pain other than HIC that may affect assessments in this study * Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study * Patients receiving medications for psychiatric disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06752603). StuddyBuddy aggregates publicly available trial information.